Arthur J Higgins
CIK 1142083 · Director, President and CEO · last filed 2026-10-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ECL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
P.O. BOX 708
WARSAW, IN 46580
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ZBH | Director | 2,900 | $94.98 | $275.4K | $540.7K | 106 | 2026-10-02 |
| ECL | Director | 26,741 | $288.89 | $7.73M | -$4.67M | 80 | 2025-04-02 |
| Assertio Holdings, Inc. (ASRT) Delisted | Director, President and CEO | 9,454 | $23.50 | $222.2K | $177.1K | 13 | 2020-12-07 |
| ECOLAB INC. (ECL.WD) Delisted | Director | 19,503 | — | — | -$806.6K | 1 | 2020-06-03 |
| Assertio Therapeutics, Inc (DEPO) Delisted | President and CEO | 126,760 | — | — | $760.8K | 5 | 2018-02-08 |
| Endo International plc (ENDP) Delisted | Director | 50,623 | $0.29 | $14.8K | $1.04M | 10 | 2016-05-12 |
Recent Filings · Page 3 of 22
219 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-14 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2024-05-08 | ECL | Mixed | — | -$511.1K | EDGAR |
| 2024-05-06 | ECL | Notice (144) | −4,500 | -$1.02M | EDGAR |
| 2024-04-02 | ECL | Grant (A) | +281 | $31.2K | EDGAR |
| 2024-04-02 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2024-01-03 | ECL | Grant (A) | +308 | $30.0K | EDGAR |
| 2024-01-03 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2023-10-03 | ECL | Grant (A) | +360 | $30.0K | EDGAR |
| 2023-10-03 | ZBH | Grant (A) | — | $0 | EDGAR |
| 2023-08-25 | ZBH | Buy (P) | +1,000 | $115.6K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.